Patents by Inventor J. Darrell Fontenot

J. Darrell Fontenot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
    Patent number: 5827666
    Abstract: The present invention relates to novel synthetic muc-1 peptides and muc-1-like analogs including at least two 20-amino acid tandem repeats of muc-1, which synthetic muc-1 and muc-1-like peptides are capable of attaining native conformation in the absence of glycosylation. The invention also relates to methods of producing the peptides. The invention further relates to uses of the peptides, such as for vaccines and diagnostic testing.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: October 27, 1998
    Assignee: University of Pittsburgh
    Inventors: Olivera J. Finn, J. Darrell Fontenot, Ronald C. Montelaro
  • Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
    Patent number: 5744144
    Abstract: The present invention relates to novel synthetic muc-1 peptides and muc-1 analogs comprising at least two 20-amino acid tandem repeats of muc-1, wherein said synthetic muc-1 peptide is capable of attaining native conformation in the absence of glycosylation. The invention also relates methods of producing the peptides. The invention further relates to uses of the peptides, such as for vaccines and diagnostic testing.
    Type: Grant
    Filed: July 30, 1993
    Date of Patent: April 28, 1998
    Assignee: University Of Pittsburgh University Patent Committee Policy And Procedures
    Inventors: Olivera J. Finn, J. Darrell Fontenot, Ronald C. Montelaro
  • Peptide vaccines and associated methods for protection against feline leukemia virus
    Patent number: 5609876
    Abstract: The present invention discloses peptide vaccines and associated methods for protection against feline leukemia virus (FeLV). The synthetic peptides of the present invention retain their secondary structural identity, stimulate antibodies reactive to the whole virus and elicit a cellular response in vaccinations. These synthetic peptides are inexpensive to produce, stable and permit easy differentiation of vaccinated versus FeLV-infected cats.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: March 11, 1997
    Assignee: University of Pittsburgh of the Commonwealth System of Higher Education
    Inventors: Ronald C. Montelaro, J. Darrell Fontenot